This brand name is authorized in Austria, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Poland, United Kingdom, United States
The drug QUADRAMET contains one active pharmaceutical ingredient (API):
|
1
Samarium ¹⁵³Sm lexidronam
UNII 745X144DZY - SAMARIUM SM-153 LEXIDRONAM
|
|
Samarium has an affinity for skeletal tissue and concentrates in areas of bone turnover in intimate association with hydroxyapatite. It is indicated for the relief of bone pain in patients with multiple painful osteoblastic skeletal metastases which take up technetium (99mTc)-labelled biphosphonates on bone scan. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| QUADRAMET Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V10BX02 | Samarium (153Sm) lexidronam | V Various → V10 Therapeutic radiopharmaceuticals → V10B Pain palliation (bone seeking agents) → V10BX Various pain palliation radiopharmaceuticals |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1197301 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 98057001 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 68052014 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 394528, 394587, 394593, 394596, 394600, 394607, 394610, 394613, 394635, 394639, 394644, 394647, 394652, 394656, 394660, 394667, 394671, 394675, 394679, 394683, 394687 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 033111016 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1030554 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100110300 |
| Country: US | FDA, National Drug Code | Identifier(s): 11994-016 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
